Healthcare Sales & Marketing Network News: Spero Therapeutics

Searching News Database: Spero Therapeutics

HSMN NewsFeed - 11 Feb 2021
Dewpoint Therapeutics Appoints Joel Sendek as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2019
F2G Appoints Dr. Patrick Vink as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2017
Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.